Focused antibody response in plasma cell-infiltrated non-medullary (NOS) breast cancers

Breast Cancer Research and Treatment

Volumn 104, Issue 2, 2007, Pages 129-144

  Wang, Y ^a,b   Ylera, F ^a,b   Boston, M ^a,b   Kang, S G ^a,b   Kutok, J L ^c   Klein Szanto, A J P ^d   Junghans, R P ^a,b,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; IgG; Not otherwise specified (NOS); Plasma cell; Repertoire focus

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; TUMOR ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BREAST CANCER; BREAST TUMOR; CELL INFILTRATION; CLONAL VARIATION; CONTROLLED STUDY; GENETIC SELECTION; HEAVY CHAIN; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; LIGHT CHAIN; MEDULLARY CARCINOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; SOMATIC HYPERMUTATION; STEM CELL;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BASE SEQUENCE; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; PLASMA CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 34447513155     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9409-3     Document Type: Article

References (44)

1. DeVita VT, Hellman S, Rosenberg SA (1989) Cancer, principles and practice of oncology. J. B. Lippincott, Philadelphia, p1205
2. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V (1977) Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 40:1365-1385
3. Ito T, Saga S, Nagayoshi S, Imai M, Aoyama A, Yokoi T, Hoshino M (1986) Class distribution of immunoglobulin-containing plasma cells in the stroma of medullary carcinoma of breast. Breast Cancer Res Treat 7:97-103
4. Gaffey MJ, Frierson HF Jr, Mills SE, Boyd JC, Zarbo RJ, Simpson JF, Gross LK, Weiss LM (1993) Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 6:721-728
5. Kotlan B, Gruel N, Zafrani B, Furedi G, Foldi J, Petranyi GG, Fridman WH, Teillaud JL (1999) Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma. Immunol Lett 65:143-151
6. Coronella JA, Telleman P, Kingsbury GA, Truong TD, Hays S, Junghans RP (2001) Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer. Cancer Res 61:7889-7899
7. Hansen MH, Nielsen H, Ditzel HJ (2001) The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proc Natl Acad Sci USA 98:12659-12664
8. Coronella JA, Telleman P, Truong TD, Ylera F, Junghans RP (2000) Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells. Nucleic Acids Res 28:E85
9. Barbas III CF, Burton DR, Scott JK, Silverman GJ (2001) Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, pp 9.7-9.9
10. Lefranc MP, Giudicelli V, Ginestoux C, Bodmer J, Muller W, Bontrop R, Lemaitre M, Malik A, Barbie V, Chaume D (1999) IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 27:209-212
11. Lossos IS, Tibshirani R, Narasimhan B, Levy R (2000) The inference of antigen selection on Ig genes. J Immunol 165:5122-5126
12. Georgiannos SN, Renaut A, Goode AW, Sheaff M (2003) The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery 134:827-834
13. Ohlin M, Borrebaeck CA (1996) Characteristics of human antibody repertoires following active immune responses in vivo. Mol Immunol 33:583-592
14. Guigou V, Cuisinier AM, Tonnelle C, Moinier D, Fougereau M, Fumoux F (1990) Human immunoglobulin VH and VK repertoire revealed by in situ hybridization. Mol Immunol 27:935-940
15. Stewart AK, Huang C, Long AA, Stollar BD, Schwartz RS (1992) VH-gene representation in autoantibodies reflects the normal human B-cell repertoire. Immunol Rev 128:101-122
16. Schutte ME, van Es JH, Silberstein LE, Logtenberg T (1993) VH4.21-encoded natural autoantibodies with anti-i specificity mirror those associated with cold hemagglutinin disease. J Immunol 151:6569-6576
17. Cox JP, Tomlinson IM, Winter G (1994) A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol 24:827-836
18. Klein R, Jaenichen R, Zachau HG (1993) Expressed human immunoglobulin kappa genes and their hypermutation. Eur J Immunol 23:3248-3262
19. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ et al (1994) Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13:3245-3260
20. Combriato G, Klobeck HG (1991) V lambda and J lambda-C lambda gene segments of the human immunoglobulin lambda light chain locus are separated by 14 kb and rearrange by a deletion mechanism. Eur J Immunol 21:1513-1522
21. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G (1991) Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 173:395-407
22. Wilson IA, Stanfield RL, Rini JM, Arevalo JH, Schulze-Gahmen U, Fremont DH, Stura EA (1991) Structural aspects of antibodies and antibody-antigen complexes. In: Catalytic Antibodies. Ciba Found Symp 159:13-39
23. Krenn V, Konig A, Hensel F, Berek C, Souto Carneiro MM, Haedicke W, Wang Y, Vollmers H, Muller-Hermelink HK (1999) Molecular analysis of rheumatoid factor (RF)-negative B cell hybridomas from rheumatoid synovial tissue: evidence for an antigen-induced stimulation with selection of high mutated IgVH and low mutated IgVL/lambda genes. Clin Exp Immunol 115:168-175
24. Clark LA, Ganesan S, Papp S, van Vlijmen HW (2006) Trends in antibody sequence changes during the somatic hypermutation process. J Immunol 177:333-340
25. Kim HJ, Berek C (2000) B cells in rheumatoid arthritis. Arthritis Res 2:126-131
26. Lippman ME (1993) The development of biological therapies for breast cancer. Science 259:631-632
27. Berg JW, Robbins GF (1968) Tumors of the breast. In: RW McDivitt, FW Stewart, JW Berg (eds) Atlas of Tumor Pathology 2nd series. Washington, DC: Armed Forces Institute of Pathology, pp 60-61
28. Sieinski W (1980) Immunohistological patterns of immunoglobulins in dysplasias, benign neoplasms and carcinomas of the breast. Tumori 66:699-711
29. Scheinberg DA, Mulford DA, Jurcic JG, Sgouros G, Junghans RP (2006) Antibody therapies of cancer. In: Chabner BA, Longo DL (ed), Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott, Wheeler and Wilkins, Philadelphia, 666-698
30. Jacquemier J, Piana L, Torrente M, Hassoun J (1987) Immunohistochemical study of T and B lymphocytes in human breast carcinomas with inflammatory stroma. Breast Dis 2:12-20
31. Hansen MH, Nielsen HV, Ditzel HJ (2002) Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells. J Immunol 169:2701-2711
32. Lee SK, Bridges SL Jr, Kirkham PM, Koopman WJ, Schroeder HW Jr (1994) Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis. J Clin Invest 93:361-370
33. Gruel N, Kotlan B, Beuzard M, Teillaud JL (2002) Generation of scFv from a phage display mini-library derived from tumor-infiltrating B-cells. Methods Mol Biol 193:281-300
34. Kotlan B, Simsa P, Gruel N, Foldi J, Fridman WH, Petranyi G, Teillaud JL (2000) A scFv phage display mini library generated from the immunoglobulin repertoire of breast medullary carcinoma infiltrating B lymphocytes. Dis Markers 16:25-27
35. Dorner T, Lipsky PE (2001) Immunoglobulin variable-region gene usage in systemic autoimmune diseases. Arthritis Rheum 44:2715-2727
36. Huang C, Stewart AK, Schwartz RS, Stollar BD (1992) Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest 89:1331-1343
37. Nzula S, Going JJ, Stott DI (2003) Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 63:3275-3280
38. Simsa P, Teillaud JL, Stott DI, Toth J, Kotlan B (2005) Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma. Pathol Oncol Res 11:92-97
39. Coronella JA, Spier C, Welch M, Trevor KT, Stopeck AT, Villar H, Hersh EM (2002) Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 169:1829-1836
40. Manser T (2004) Textbook germinal centers. J Immunol 172:3369-3375
41. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS (1996) Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 14:309-314
42. Kotlan B, Simsa P, Teillaud JL, Fridman WH, Toth J, McKnight M, Glassy MC (2005) Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes. J Immunol 175:2278-2285
43. Whitford P, Mallon EA, George WD, Campbell AM (1990) Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer 62:971-975
44. Mathoulin MP, Xerri L, Jacquemier J, Adelaide J, Parc P, Hassoun J (1993) Unrestricted T-cell receptor V-region gene repertoire in tumor-infiltrating lymphocytes from human breast carcinomas. Cancer 72:506-510